Big Difference in Early Adoption of Radiotherapy Modalities for Prostate Cancer Big Difference in Early Adoption of Radiotherapy Modalities for Prostate Cancer
The rates of early adoption of intensity-modulated radiotherapy (IMRT) and stereotactic body radiation therapy (SBRT) for older men with prostate cancer differ markedly, according to an analysis of data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare database.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - April 4, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news

IMRT associated with reduction in patient reported xerostomia
(NRG Oncology) A pooled analysis of data from NRG Oncology studies RTOG 0129 and 0522 compared intensity-modulated radiotherapy (IMRT) with three-dimensional conformal radiotherapy for patients treated for locally advanced head and neck squamous cell carcinoma. The study found that IMRT was associated with significantly reduced xerostomia and feeding tube dependency after treatment, especially in oropharyngeal cancer patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2016 Category: Cancer & Oncology Source Type: news

Intensity modulated pelvic radiation therapy reduces patient reported toxicities
(NRG Oncology) NRG Oncology investigators report better patient-reported quality of life measures for women who received intensity modulated radiation therapy (IMRT) for their pelvic radiation therapy (RT) than those who received standard RT. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2016 Category: Cancer & Oncology Source Type: news

ASCO releases updated breast RT guideline
The American Society of Clinical Oncology (ASCO) has released an updated guideline...Read more on AuntMinnie.comRelated Reading: New treatment guidelines issued for DCIS ASCO BCS: Breast MRI useful for average-risk women, too ASCO BCS research highlights benefits of mobile mammo, PET/MR ASTRO publishes guidelines for accelerated whole-breast RT IMRT reduces skin toxicity symptoms for breast cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 29, 2016 Category: Radiology Source Type: news

Is IMRT for Gynecologic Cancers Less Toxic? Is IMRT for Gynecologic Cancers Less Toxic?
Pelvic IMRT reduces acute patient-reported toxicity compared to standard pelvic radiation therapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 28, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Link between facility volume, radiation outcomes for head and neck cancers
The association between provider case volume and outcomes has long been suggested in cancer care. A research team has completed a review of outcomes for patients with locally advanced squamous cell head and neck cancers treated with intensity-modulated radiation therapy (IMRT) and found a distinct association between higher-volume treatment centers and improved overall survival. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 27, 2016 Category: Science Source Type: news

Accuray touts 5-year CyberKnife data in prostate cancer trial
Accuray (NSDQ:ARAY) today released 5-year data from a study of its CyberKnife stereotactic body radiotherapy device for treating prostate cancer, touting a 97% rate of freedom from cancer after treatment at 5-years. Results from the study were presented at the American Society for Therapeutic Radiology and Oncology’s annual meeting in Boston. The 21-site, 309-patient trial looked to examine whether dose-escalated SBRT can be administered across multiple institutions without grade 3+ toxicities exceeding 10%. The study followed patients for 5 years and reported toxicity, survival and relapse-free survival outcome...
Source: Mass Device - September 26, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Oncology Radiosurgery Accuray Inc. Source Type: news

Postop IMRT Reduces Bowel Obstruction in GYN Cancer (CME/CE)
(MedPage Today) -- Women with BMIs>30 less likely to develop bowel obstruction (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 23, 2016 Category: Hematology Source Type: news

Many Mesothelioma Centers Top List of Best Cancer Hospitals
The University of Texas MD Anderson Cancer Center retained its standing as the top cancer care hospital in the nation for the second consecutive year, according to U.S. News & World Report. The publication’s 2016-17 Best Hospitals for Cancer graded cancer centers from 0-100 on a variety of categories such as reputation with specialists, volume of high-risk patients, patient survival and safety, nurse intensity and advanced technologies. The purpose: Help patients make more informed health care decisions. “It’s important for patients to know that not all hospitals deliver equivalent levels of care,&rdq...
Source: Asbestos and Mesothelioma News - August 11, 2016 Category: Environmental Health Authors: Walter Pacheco Tags: best cancer centers best cancer hospitals best hospitals for cancer best hospitals rankings best mesothelioma cancer centers md anderson cancer center mesothelioma treatment moffitt cancer center us news and world report best hospitals Source Type: news

Accuray wins FDA nod for Radixact image-guided radiotherapy
Accuray (NSDQ:ARAY) said today it won FDA 510(k) clearance for its Radixact treatment delivery platform designed for image-guided radiotherapy treatments designed for cancer patients. The company said it also won FDA clearance for its Accuray Precision treatment planning system and iDMS data management system, components of its Radixact treatment platform. “The Radixact system builds upon the unique strengths of the TomoTherapy platform. Expanded delivery capabilities enable treatment with image-guided, intensity-modulated radiation therapy to an expanded range of patients. New database features make the ring ga...
Source: Mass Device - June 27, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Radiosurgery Regulatory/Compliance Accuray Inc. Source Type: news

Finally, RCT Results for Proton Therapy in a CancerFinally, RCT Results for Proton Therapy in a Cancer
Results from the first randomized controlled trial of proton therapy indicate that the new technology is no better than IMRT in the treatment of lung cancer. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 21, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Study finds adaptive IGRT for bladder preservation clinically feasible
(American Society for Radiation Oncology) A prospective study examining a trimodality treatment approach in localized bladder cancer cases using adaptive image-guided, intensity-modulated radiation therapy (IG-IMRT) found that the bladder preservation rate at three years was 83 percent. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 29, 2016 Category: Cancer & Oncology Source Type: news

New Elekta iViewDose Software Designed to Provide an Essential Safety Check for Radiation Therapy
EPID-based in vivo patient dosimetry for error detection receives US FDA 510(k) clearance and CE Mark CRAWLEY, England, March 1, 2016 -- (Healthcare Sales & Marketing Network) -- The use of highly-focused, rapid delivery techniques such as intensity mo... Devices, Oncology, Product LaunchElekta, iViewDose, dosimetry, IMRT, VMAT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 1, 2016 Category: Pharmaceuticals Source Type: news

Experience Can Count in Radiation for Head-and-Neck CancerExperience Can Count in Radiation for Head-and-Neck Cancer
Head-and-neck cancer (HNC) patients treated with intensity modulated radiotherapy (IMRT) do better when radiation oncologists are more experienced, according to U.S. and Chinese researchers. Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - January 12, 2016 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Diagnosed With Prostate Cancer, Now What: A New Study Shows That Surgery Is the Best Option
With prostate cancer being one of the leading cancers in men, finding the best way to treat it has become increasingly important. A new study points to why surgery might be the best long term treatment option, especially for men with localized prostate cancer. Researchers from Odette Caner Centre, Sunnybrook Research Institute (University of Toronto, Canada) conducted a meta-analysis of 19 studies comparing the success/survival rates of surgery vs. radiation. All in all, this added up to about 120,000 men who received either surgery or radiation as treatment for their localized prostate cancer. What researchers found was t...
Source: Healthy Living - The Huffington Post - December 17, 2015 Category: Consumer Health News Source Type: news

SMART Approach Is Advancing Mesothelioma Survival Rates
Accelerated high-dose radiation just before extrapleural pneumonectomy (EPP) surgery — a reversal of the traditional order at most U.S. specialty centers — continues to produce impressive results for pleural mesothelioma patients in Toronto. Specialists at the Princess Margaret Cancer Centre and Toronto General Hospital estimated the median overall survival and disease-free survival at 51 and 47 months, respectively, for patients with the most common subtype of the disease. Surgeon Marc de Perrot presented the findings of an ongoing study earlier this year at the American Association for Thoracic Surgery in S...
Source: Asbestos and Mesothelioma News - December 14, 2015 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Nestor Villamizar Grows Mesothelioma Program in Miami
Thoracic surgeon Nestor Villamizar saw the glaring need for a comprehensive mesothelioma program in bustling South Florida, even when he was 1,500 miles away in Boston. He is filling that void today. Villamizar joined the Sylvester Comprehensive Cancer Center in 2014, hoping to slow the stream of mesothelioma patients who are leaving Florida to seek treatment at Brigham and Women's Hospital in Boston. He has been a much-welcomed addition to the state. The early results are impressive. "When I was working at the Brigham, we kept seeing more and more mesothelioma patients coming for surgery from Florida, and it alw...
Source: Asbestos and Mesothelioma News - December 3, 2015 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Cost to treat low-risk prostate cancer can vary widely, UCLA study finds
How much does it actually cost to treat low-risk prostate cancer? A team of UCLA researchers are the first to describe the cost throughout the entire process for men being treated for low-risk prostate cancer — from their first appointment to post-treatment follow-up testing. Analyzing several different types of cancer treatment that were available throughout the entire 12-year study period, the researchers found a wide variance in costs. The research indicates that there may be a better way to monitor costs and keep them in check for patients, said Dr. Aaron Laviana, the study’s first author. “As we move...
Source: UCLA Newsroom: Health Sciences - November 3, 2015 Category: Universities & Medical Training Source Type: news

'No Brainer': IMRT for Locally Advanced NSCLC 'No Brainer': IMRT for Locally Advanced NSCLC
Intensity-modulated radiotherapy (IMRT) is associated with fewer adverse events than standard radiotherapy and should now be considered routinely, say researchers. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 24, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

IMRT Reduces Toxicity in Unresectable NSCLC (CME/CE)
(MedPage Today) -- Survival similar to 3D-CRT with less lung, heart toxicity (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 21, 2015 Category: Hematology Source Type: news

ASTRO: Shorter RT works for low-risk prostate cancer
Hypofractionated radiation therapy (RT) yields similar rates of cure and side...Read more on AuntMinnie.comRelated Reading: Shortened RT for prostate cancer may not be better Prostate cancer rad therapy may cause other cancers Proton therapy succeeds in treating prostate cancer NEJM: Urologist self-referral equals IMRT overuse Prostate cancer patients get too much radiation therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 21, 2015 Category: Radiology Source Type: news

Shortened RT for prostate cancer may not be better
Hypofractionated radiation therapy (RT) isn't necessarily better for prostate...Read more on AuntMinnie.comRelated Reading: Prostate cancer rad therapy may cause other cancers Proton therapy succeeds in treating prostate cancer NEJM: Urologist self-referral equals IMRT overuse Prostate cancer patients get too much radiation therapy Proton therapy groups praise GAO prostate cancer report (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 19, 2015 Category: Radiology Source Type: news

For lung cancer patients, IMRT associated with lesser side effects, better tolerance of chemotherapy, compared to conventional radiation therapy
An analysis of an international, cooperative-led trial of patients with locally advanced non-small cell lung cancer (NSCLC) has shown that those who received intensity modulated radiation therapy (IMRT) had less severe lung toxicity and were able to better tolerate their chemotherapy, compared to patients who received 3-dimensional conformal radiation therapy (3-D CRT). (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - October 19, 2015 Category: Cancer & Oncology Source Type: news

For lung cancer patients, IMRT associated with lesser side effects, better tolerance of chemotherapy, compared to conventional radiation therapy
(University of Texas M. D. Anderson Cancer Center) An analysis of an international, cooperative-led trial of patients with locally advanced non-small cell lung cancer has shown that those who received intensity modulated radiation therapy had less severe lung toxicity and were able to better tolerate their chemotherapy, compared to patients who received 3-D conformal radiation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 18, 2015 Category: Cancer & Oncology Source Type: news

High-Dose-Rate Brachytherapy in Prostate Cancer: What Role?High-Dose-Rate Brachytherapy in Prostate Cancer: What Role?
Dr Gerald Chodak talks about the potential role of this treatment approach, alone or in combination with intensity-modulated radiation therapy, in high-risk prostate cancer. Medscape Urology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 16, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

A New Treatment Approach for Relapsing Prostate...
IMRT coupled with optimal scanning technology can result in durable remissions and a freedom from dependency on lifelong hormonal therapy. (Source: About.com Prostate Cancer)
Source: About.com Prostate Cancer - October 2, 2015 Category: Cancer & Oncology Tags: health Source Type: news

Seattle Cancer Center Using SMART Mesothelioma Treatment
A Toronto-based groundbreaking approach to treating mesothelioma has crossed the Canadian border and is now part of an innovative Seattle cancer treatment center. Officials at the Swedish Cancer Institute in Seattle recently adopted the Surgery for Mesothelioma After Radiation Therapy (SMART) approach that originated at the Princess Margaret Cancer Center in Toronto. The therapy is a significant shift from the traditional lower-dose, radiation-after-surgery method to a more high-intensity approach that has more than doubled the three-year survival rate for pleural mesothelioma patients. Officials at the Swedish Cancer...
Source: Asbestos and Mesothelioma News - July 27, 2015 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Extended-field intensity modulated radiation therapy for cervical and endometrial cancers does not increase risk of duodenal toxicity
A study of women with cervical or endometrial cancer who require treatment to the para-aortic (PA) lymph nodes can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity, scientists report. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 7, 2015 Category: Science Source Type: news

Extended-field IMRT does not increase duodenal toxicity risk
(American Society for Radiation Oncology) A study of women with cervical or endometrial cancer who require treatment to the para-aortic (PA) lymph nodes can safely receive extended-field intensity modulated radiation therapy without increased risk of duodenal toxicity, according to a study published in the July-August 2015 issue of Practical Radiation Oncology, the American Society for Radiation Oncology's journal focused on the clinical practice of radiation oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2015 Category: Cancer & Oncology Source Type: news

First TomoTherapy(R) System in Latin America Dedicated Solely to Breast Cancer Care Now Treating Patients
Advanced Radiation Therapy System Ideally Suited for Efficient, Effective Treatment of Range of Breast Cancer Cases SUNNYVALE, Calif., Feb. 4, 2015 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that the first ... Devices, Radiology, OncologyAccuray, TomoTherapy, radiation therapy, IG-IMRT, TomoHelical (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 4, 2015 Category: Pharmaceuticals Source Type: news

Improved Radiation Therapy Extends Lives of Mesothelioma Patients
This study gives a definitive edge to the P/D procedure. Median overall survival was 28.4 months for the P/D group compared to just 14.2 months for the EPP group. The progression free survival was 16.4 months for P/D, compared to 8.2 months for the EPP patients. The over survival and progression free survival at the one-year mark for P/D patients was 76 and 67 percent, respectively. It was 56 and 34 percent at two years. For the EPP patients, the overall survival was 55 percent and the progression free survival was 44 percent at one year. Radiation Causes Pulmonary Decline There was one noted downside to the IMRT that has...
Source: Asbestos and Mesothelioma News - December 30, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Acclerated IMRT Comparable to WBI at 5 YearsAcclerated IMRT Comparable to WBI at 5 Years
Outcomes were similar between accelerated partial intensity-modulated radiation therapy (IMRT) and whole breast irridation (WBI), but it may not be worth the extra cost of the technique. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 16, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

In Sinonasal Cancer, New Radiotherapy Trumps Old?In Sinonasal Cancer, New Radiotherapy Trumps Old?
A meta-analysis compares charged-particle, including proton beam, therapy with the more established photon therapy, including IMRT. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 10, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Study: Proton beam therapy tops IMRT
Proton beam therapy can provide significantly better disease-free survival (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 7, 2014 Category: Radiology Source Type: news

Mayo Clinic: Proton therapy has advantages over IMRT for advanced head and neck cancers
(Mayo Clinic) A new study by radiation oncologists at Mayo Clinic comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free survival and tumor control when compared to IMRT. The results appear in the journal Lancet Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 1, 2014 Category: Global & Universal Source Type: news

Proton therapy has advantages over IMRT for advanced head and neck cancers, Mayo study finds
Rochester, Minn. -- A new study by radiation oncologists at Mayo Clinic comparing the world’s literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base compared to intensity modulated radiation therapy (IMRT) has found that proton beam therapy significantly improved disease free [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - July 1, 2014 Category: Research Source Type: news

Gene therapy combined with IMRT reduces rate of positive prostate biopsy after treatment for intermediate-risk prostate cancer patients
Combining oncolytic adenovirus-mediated cytotoxic gene therapy (OAMCGT) with intensity modulated radiation therapy (IMRT) reduces the risk of having a positive prostate biopsy two years after treatment in intermediate-risk prostate cancer without affecting patients’ quality of life, research has determined. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 2, 2014 Category: Science Source Type: news

Gene therapy combined with IMRT found to reduce recurrence for select prostate cancer patients
(American Society for Radiation Oncology) Combining oncolytic adenovirus-mediated cytotoxic gene therapy with intensity modulated radiation therapy reduces the risk of having a positive prostate biopsy two years after treatment in intermediate-risk prostate cancer without affecting patients' quality of life. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 2, 2014 Category: Cancer & Oncology Source Type: news

40 E-Books New to Scott Library in April
Scott Library added these 40 eBooks in April to the growing collection: ACLS, CPR and PALS: clinical pocket guide Anatomic pathology Anatomic pathology flashcards Atlas of EEG patterns Atlas of ultrasound in obstetrics and gynecology: a multimedia reference Basic musculoskeletal imaging Behavioral science in medicine (2nd ed.) Breast imaging (radiology case review series) Cardiovascular physiology (8th ed.) Cervical spine, the (5th ed.) Clinical anatomy of the spine, spinal cord, and ANS (3rd ed.) Clinical anesthesiology board review: a test simulation and self-assessment tool (2nd ed.) Communication, collaboration and y...
Source: What's New on JEFFLINE - May 5, 2014 Category: Databases & Libraries Authors: Gary Kaplan Tags: All News Clinicians Researchers Students Teaching Faculty Source Type: news

Hypofractionated IMRT, Prostate Cancer, and Late ToxicitiesHypofractionated IMRT, Prostate Cancer, and Late Toxicities
Hypofractionated radiation has multiple advantages over the conventional approach, but it is still not widely used, and toxicities are a concern. A new study offers insights. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 24, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Dr. Stevens Wants Beaumont to Be Midwest Leader in Mesothelioma Treatment
Craig Stevens, M.D., has heard too many stories about patients with mesothelioma leaving Michigan to seek treatment elsewhere, searching for the best, specialized care they could find. He wants to stop that exodus by making the Beaumont Cancer Institute in suburban Detroit the best regional center for mesothelioma treatment. Stevens is the recently-appointed chairman of the Radiation Oncology Department at Beaumont. He is a pioneer in the use of Intensity Modulated Radiation Therapy (IMRT) and a specialist in the treatment of pleural mesothelioma, a rare and aggressive cancer. He wants to build and integrate a new speci...
Source: Asbestos and Mesothelioma News - April 21, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Fox Chase Committing Its Best to Mesothelioma Treatment
The Fox Chase Cancer Center in Philadelphia doesn't handle as many pleural mesothelioma cases as some of the other specialty centers, but the care it provides them and outcomes it produces are second to none. Mesothelioma cancer is a high priority. "I don't think you can get better care anywhere else," said Walter Scott, M.D., chief of thoracic surgical oncology at Fox Chase. "We've got the experts with experience. And we've got that great support team around them." Scott spoke at the conclusion of the sixth annual Advances in Thoracic Oncology Conference last week. The program, which included presen...
Source: Asbestos and Mesothelioma News - April 3, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Dose-escalated hypofractionated IMRT, conventional IMRT for prostate cancer have like side effects
(American Society for Radiation Oncology) Dose-escalated intensity modulated radiation therapy with use of a moderate hypofractionation regimen -- 72 Gy in 2.4 Gy fractions -- can safely treat patients with localized prostate cancer with limited grade 2 or 3 late toxicity, according to a study published in the Apr. 1, 2014, edition of the International Journal of Radiation Oncology · Biology · Physics -- Red Journal -- the official scientific journal of the American Society for Radiation Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 3, 2014 Category: Cancer & Oncology Source Type: news

SBRT Cheaper but More Toxic Than IMRT for Prostate CancerSBRT Cheaper but More Toxic Than IMRT for Prostate Cancer
Stereotactic body radiotherapy (SBRT) is cheaper but more toxic than intensity-modulated radiotherapy (IMRT) for prostate cancer, according to a comparative study. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 13, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Convenient, less expensive, but possibly riskier new prostate cancer treatment: SBRT
A faster and less expensive form of radiotherapy for treating prostate cancer may come at a price, according to a new study by Yale School of Medicine researchers - a higher rate of urinary complications.The standard external beam radiation therapy for prostate cancer is called intensity modulated radiation therapy (IMRT). Stereotactic body radiotherapy (SBRT) is a newer treatment that delivers a greater dose of radiation per treatment than IMRT. As a result, patients receiving SBRT can complete an entire course of treatment in one to two weeks, compared to seven to nine weeks for IMRT. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 12, 2014 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

SMART Procedure Doubles Survival Rate for Mesothelioma Patients
Treating pleural mesothelioma with high-dose radiation just before aggressive surgery, a reversal of the traditional procedure, can double the three-year survival rate, according to recently published clinical research at the Princess Margaret Cancer Centre in Toronto. The cancer center is the first in the world to study a significant number of patients using the Surgery for Mesothelioma After Radiation Therapy (SMART) and the approach is now the standard of care in Toronto. "I'm biased, and don't want to toot our own horn too loudly, but very few places have come close to the results we've seen here,"...
Source: Asbestos and Mesothelioma News - January 27, 2014 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

IMRT confers survival benefit for head and neck cancer
Patients with head and neck cancer who received intensity-modulated radiation (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 20, 2014 Category: Radiology Source Type: news

Study finds more targeted form of radiation improves survival in patients with head and neck cancers
Patients with cancers of the head and neck who  received intensity-modulated radiation therapy (IMRT)  - a technology designed to more precisely target cancer cells and spare nearby tissue -  experienced improved outcomes, as well as reduced toxicities, compared to patients receiving conventional radiation therapy, according to new research from The University of Texas MD Anderson Cancer Center. (Source: M. D. Anderson Cancer Center - News Releases)
Source: M. D. Anderson Cancer Center - News Releases - January 15, 2014 Category: Cancer & Oncology Source Type: news

Head, Neck Ca Survival Better With IMRT
(MedPage Today) -- Patients with head and neck cancers had significantly better cancer-specific survival when treated with intensity modulated radiation therapy instead of conventional RT, a review of a large database showed. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 13, 2014 Category: Primary Care Source Type: news

Study finds more targeted form of radiation improves survival in patients with head and neck cancers
(University of Texas M. D. Anderson Cancer Center) IMRT reduces side effects, also improves outcomes. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 13, 2014 Category: Cancer & Oncology Source Type: news